OCONNELL MAUREEN

SEC source: 0001111318-26-000012 · wk-form4_1788552055.xml · nonDerivative · entry 2

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,655

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.51 to $4.66, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form.

SEC source: 0001111318-26-000012 · wk-form4_1788552055.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,121

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.615 to $4.645, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form.

SEC source: 0001111318-26-000009 · wk-form4_1787268188.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,655

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.57 to $4.63, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form.

SEC source: 0001111318-26-000005 · wk-form4_1782842230.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,235

F1 · shares: Represents shares purchased under the Company's Deferred Compensation Plan representing partial payment of annual director retainer.

F2 · balance_after: Total includes previously reported restricted stock units.

F3 · balance_after: Ownership includes shares received as a dividend.

SEC source: 0001111318-26-000003 · wk-form4_1782418329.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 297,655

F1 · shares: Grant of restricted stock awarded on June 23, 2026, as part of the Company's annual grant of equity awards to non-employee directors, pursuant to the 2024 Acacia Research Corporation Stock Incentive Plan. 100% of the restricted stock will vest on the first anniversary of the grant date.

SEC source: 0000097216-26-000043 · wk-form4_1773097715.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,351

F1 · shares: Represents shares purchased under the Company's Deferred Compensation Plan representing partial payment of prorata annual director retainer.

F2 · balance_after: Total includes previously reported restricted stock units.

SEC source: 0000950103-26-001466 · dp240898_4-oconnell.xml · nonDerivative · entry 2

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: On February 2, 2026, pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 29, 2025, by and among Terex Corporation, a Delaware corporation ("Terex"), Tag Merger Sub 1 Inc. ("Merger Sub 1"), a Delaware corporation and wholly owned subsidiary of Terex, Tag Merger Sub 2 LLC, a Delaware limited liability company and wholly owned subsidiary of Terex ("Merger Sub 2"), and REV Group, Inc. (the "Issuer"), among other things, Merger Sub 1 merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Terex (the "First Merger"). Immediately following the First Merger, Issuer merged with and into Merger Sub 2, with Merger Sub 2 continuing as the surviving corporation and a wholly owned subsidiary of Terex.

F3 · shares: At the Effective Time, each outstanding restricted stock unit award of the Issuer ("Issuer RSU Award") held by the reporting person as of immediately prior to the Effective Time, whether or not vested, was cancelled and converted into a Terex RSU Award covering a number of shares of Terex Common Stock equal to (i) the number of shares of Issuer Common Stock subject to the Issuer RSU Award as of immediately prior to the Effective Time, multiplied by (ii) 1.1309. The dividend equivalents accrued, but unpaid, with respect to each such Issuer RSU Award were converted to a restricted cash payment ("RSU Restricted Cash Payment"). The resulting Terex RSU Awards and RSU Restricted Cash Payments are each generally subject to the same vesting criteria as the corresponding Issuer RSU Award as of immediately prior to the Effective Time

SEC source: 0000950103-26-001466 · dp240898_4-oconnell.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,105

F1 · security: On February 2, 2026, pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 29, 2025, by and among Terex Corporation, a Delaware corporation ("Terex"), Tag Merger Sub 1 Inc. ("Merger Sub 1"), a Delaware corporation and wholly owned subsidiary of Terex, Tag Merger Sub 2 LLC, a Delaware limited liability company and wholly owned subsidiary of Terex ("Merger Sub 2"), and REV Group, Inc. (the "Issuer"), among other things, Merger Sub 1 merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Terex (the "First Merger"). Immediately following the First Merger, Issuer merged with and into Merger Sub 2, with Merger Sub 2 continuing as the surviving corporation and a wholly owned subsidiary of Terex.

F2 · shares: At the effective time of the First Merger (the "Effective Time"), each outstanding share of Issuer common stock ("Issuer Common Stock") held by the reporting person as of immediately prior to the Effective Time was cancelled and converted into the right to receive from Terex (i) 0.9809 shares of Terex common stock, par value $0.01 per share ("Terex Common Stock") and (ii) $8.71 in cash without interest.

SEC source: 0000097216-26-000022 · wk-form4_1770227396.xml · nonDerivative · entry 2

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,557

F2 · kind: At the Effective Time, each restricted stock unit ("RSU") in respect of REV Common Stock outstanding immediately prior to the Effective Time (each, a "REV RSU Award") was automatically assumed by the Issuer and converted, at the Effective Time, into (i) an award of RSUs relating to shares of Issuer Common Stock (each, a "Terex RSU Award") in respect of a number of shares of Issuer Common Stock equal to the number of shares of Rev Common Stock subject to such REV RSU Award immediately prior to the Effective Time, multiplied by the Award Exchange Ratio (as defined in the Merger Agreement and equaling 1.1309), and (ii) an amount in restricted cash equal to the amount of any dividend equivalent rights that were accrued, but unpaid, as of immediately prior to the Effective Time with respect to such REV RSU Award.

F2 · shares: At the Effective Time, each restricted stock unit ("RSU") in respect of REV Common Stock outstanding immediately prior to the Effective Time (each, a "REV RSU Award") was automatically assumed by the Issuer and converted, at the Effective Time, into (i) an award of RSUs relating to shares of Issuer Common Stock (each, a "Terex RSU Award") in respect of a number of shares of Issuer Common Stock equal to the number of shares of Rev Common Stock subject to such REV RSU Award immediately prior to the Effective Time, multiplied by the Award Exchange Ratio (as defined in the Merger Agreement and equaling 1.1309), and (ii) an amount in restricted cash equal to the amount of any dividend equivalent rights that were accrued, but unpaid, as of immediately prior to the Effective Time with respect to such REV RSU Award.

F2 · price: At the Effective Time, each restricted stock unit ("RSU") in respect of REV Common Stock outstanding immediately prior to the Effective Time (each, a "REV RSU Award") was automatically assumed by the Issuer and converted, at the Effective Time, into (i) an award of RSUs relating to shares of Issuer Common Stock (each, a "Terex RSU Award") in respect of a number of shares of Issuer Common Stock equal to the number of shares of Rev Common Stock subject to such REV RSU Award immediately prior to the Effective Time, multiplied by the Award Exchange Ratio (as defined in the Merger Agreement and equaling 1.1309), and (ii) an amount in restricted cash equal to the amount of any dividend equivalent rights that were accrued, but unpaid, as of immediately prior to the Effective Time with respect to such REV RSU Award.

F2 · acquired: At the Effective Time, each restricted stock unit ("RSU") in respect of REV Common Stock outstanding immediately prior to the Effective Time (each, a "REV RSU Award") was automatically assumed by the Issuer and converted, at the Effective Time, into (i) an award of RSUs relating to shares of Issuer Common Stock (each, a "Terex RSU Award") in respect of a number of shares of Issuer Common Stock equal to the number of shares of Rev Common Stock subject to such REV RSU Award immediately prior to the Effective Time, multiplied by the Award Exchange Ratio (as defined in the Merger Agreement and equaling 1.1309), and (ii) an amount in restricted cash equal to the amount of any dividend equivalent rights that were accrued, but unpaid, as of immediately prior to the Effective Time with respect to such REV RSU Award.

F2 · balance_after: At the Effective Time, each restricted stock unit ("RSU") in respect of REV Common Stock outstanding immediately prior to the Effective Time (each, a "REV RSU Award") was automatically assumed by the Issuer and converted, at the Effective Time, into (i) an award of RSUs relating to shares of Issuer Common Stock (each, a "Terex RSU Award") in respect of a number of shares of Issuer Common Stock equal to the number of shares of Rev Common Stock subject to such REV RSU Award immediately prior to the Effective Time, multiplied by the Award Exchange Ratio (as defined in the Merger Agreement and equaling 1.1309), and (ii) an amount in restricted cash equal to the amount of any dividend equivalent rights that were accrued, but unpaid, as of immediately prior to the Effective Time with respect to such REV RSU Award.

F3 · balance_after: Number of shares beneficially held includes 2,380 Terex RSU Awards, of which 100% will vest on December 31, 2026, subject to the continued service of the Registrant as a Director or the application of certain termination of services rights under the terms applicable to the Terex RSU Awards.

SEC source: 0000097216-26-000022 · wk-form4_1770227396.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,177

F1 · kind: In accordance with the completion of the transactions contemplated by the Agreement and Plan of Merger (such transactions, the "Mergers" and such agreement, the "Merger Agreement"), dated as of October 29, 2025, by and among the Issuer, REV Group, Inc. ("REV"), Tag Merger Sub 1 Inc. and Tag Merger Sub 2 LLC, and subject to the terms and upon the conditions set forth in the Merger Agreement, at the effective time of the Mergers occurring on February 2, 2026, (the "Effective Time"), each share of common stock of REV, $.001 par value per share ("REV Common Stock"), was converted into 0.9809 shares (the "Exchange Ratio") of common stock of the Issuer, $0.01 par value per share ("Issuer Common Stock") and $8.71 of cash merger consideration (the "Cash Merger Consideration").

F1 · shares: In accordance with the completion of the transactions contemplated by the Agreement and Plan of Merger (such transactions, the "Mergers" and such agreement, the "Merger Agreement"), dated as of October 29, 2025, by and among the Issuer, REV Group, Inc. ("REV"), Tag Merger Sub 1 Inc. and Tag Merger Sub 2 LLC, and subject to the terms and upon the conditions set forth in the Merger Agreement, at the effective time of the Mergers occurring on February 2, 2026, (the "Effective Time"), each share of common stock of REV, $.001 par value per share ("REV Common Stock"), was converted into 0.9809 shares (the "Exchange Ratio") of common stock of the Issuer, $0.01 par value per share ("Issuer Common Stock") and $8.71 of cash merger consideration (the "Cash Merger Consideration").

F1 · price: In accordance with the completion of the transactions contemplated by the Agreement and Plan of Merger (such transactions, the "Mergers" and such agreement, the "Merger Agreement"), dated as of October 29, 2025, by and among the Issuer, REV Group, Inc. ("REV"), Tag Merger Sub 1 Inc. and Tag Merger Sub 2 LLC, and subject to the terms and upon the conditions set forth in the Merger Agreement, at the effective time of the Mergers occurring on February 2, 2026, (the "Effective Time"), each share of common stock of REV, $.001 par value per share ("REV Common Stock"), was converted into 0.9809 shares (the "Exchange Ratio") of common stock of the Issuer, $0.01 par value per share ("Issuer Common Stock") and $8.71 of cash merger consideration (the "Cash Merger Consideration").

F1 · acquired: In accordance with the completion of the transactions contemplated by the Agreement and Plan of Merger (such transactions, the "Mergers" and such agreement, the "Merger Agreement"), dated as of October 29, 2025, by and among the Issuer, REV Group, Inc. ("REV"), Tag Merger Sub 1 Inc. and Tag Merger Sub 2 LLC, and subject to the terms and upon the conditions set forth in the Merger Agreement, at the effective time of the Mergers occurring on February 2, 2026, (the "Effective Time"), each share of common stock of REV, $.001 par value per share ("REV Common Stock"), was converted into 0.9809 shares (the "Exchange Ratio") of common stock of the Issuer, $0.01 par value per share ("Issuer Common Stock") and $8.71 of cash merger consideration (the "Cash Merger Consideration").

SEC source: 0000950103-25-015837 · dp238467_4-oconnell.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,539

F1 · shares: Restricted stock units with respect to REV Group, Inc. common stock vest 100% on December 31, 2026. The shares were granted under the 2016 Omnibus Incentive Plan.

SEC source: 0001111318-25-000006 · wk-form4_1748981975.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,603

F1 · shares: Grant of restricted stock awarded on May 30, 2025, as part of the Company's annual grant of equity awards to non-employee directors, pursuant to the 2024 Acacia Research Corporation Stock Incentive Plan. 100% of the restricted stock will vest on the first anniversary of the grant date.

SEC source: 0000950103-24-017518 · dp221828_4-oconnell.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,434

F1 · shares: Restricted stock units with respect to REV Group, Inc. common stock vest 100% on December 31, 2025. The shares were validly granted under the 2016 Omnibus Incentive Plan (the "Plan").

SEC source: 0001111318-24-000003 · wk-form4_1718136247.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,431

F1 · shares: Grant of restricted stock awarded on June 7, 2024, as part of the Company's annual grant of equity awards to non-employee directors, pursuant to the 2024 Acacia Research Corporation Stock Incentive Plan. 100% of the restricted stock will vest on the first anniversary of the grant date.

SEC source: 0000950103-23-017431 · dp203920_4-oconnell.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,823

F1 · shares: Restricted stock units with respect to REV Group, Inc. common stock vest 100% on December 31, 2024.

SEC source: 0000950103-23-012904 · dp199401_4-oconnell.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,739

F1 · shares: Represents shares of restricted REV Group, Inc. common stock that vest in 1 installment on December 29, 2023. The shares were validly granted under the 2016 Omnibus Incentive Plan (the "Plan").

SEC source: 0001111318-23-000002 · wk-form4_1685567853.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,310

F1 · shares: Grant of restricted stock awarded on May 26, 2023, as part of the Company's annual grant of equity awards to non-employee directors, pursuant to the 2016 Acacia Research Corporation Stock Incentive Plan. 100% of the restricted stock will vest on the first anniversary of the grant date.

SEC source: 0001111318-22-000004 · wf-form4_165229223750613.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,776

F1 · shares: Grant of restricted stock awarded on May 9, 2022, as part of the Company's annual grant of equity awards to non-employee directors, pursuant to the 2016 Acacia Research Corporation Stock Incentive Plan.

SEC source: 0001683168-21-001908 · ownership.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,575

F1 · shares: Grant of restricted stock awarded on May 10, 2021, as part of the Company's annual grant of equity awards to non-employee directors, pursuant to the 2013 Acacia Research Corporation Stock Incentive Plan.

SEC source: 0001683168-20-003064 · ownership.xml · nonDerivative · entry 2

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,914

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.71 to $3.85, inclusive. Ms. O'Connell undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4.

SEC source: 0001683168-20-003064 · ownership.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,444

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.67 to $3.83, inclusive. Ms. O'Connell undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

SEC source: 0001437749-20-019230 · rdgdoc.xml · derivative · entry 4

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,557 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSU") convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On July 27, 2018, the reporting person was granted 6,835 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date. We accelerated the vesting of this award in connection with the reporting person's departure from the Board.

F3 · derivative.expiration_date: On July 27, 2018, the reporting person was granted 6,835 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date. We accelerated the vesting of this award in connection with the reporting person's departure from the Board.

SEC source: 0001437749-20-019230 · rdgdoc.xml · nonDerivative · entry 2

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,971

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSU") convert into common stock on a one-for-one basis.

SEC source: 0001683168-20-001865 · ownership.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,914

F1 · shares: Grant of restricted stock awarded on June 2, 2020, as part of the Company's annual grant of equity awards to non-employee directors, pursuant to the 2013 Acacia Research Corporation Stock Incentive Plan.

SEC source: 0001437749-20-019230 · rdgdoc.xml · derivative · entry 3

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,136 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSU") convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On March 21 2019, the reporting person was granted 23,136 RSUs, which vest after one full year from the grant date.

F2 · derivative.expiration_date: On March 21 2019, the reporting person was granted 23,136 RSUs, which vest after one full year from the grant date.

SEC source: 0001437749-20-019230 · rdgdoc.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units ("RSU") convert into common stock on a one-for-one basis.

SEC source: 0001111318-19-000007 · wf-form4_156469268561621.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,914

F1 · shares: Grant of Restricted Stock.

SEC source: 0001111318-19-000005 · wf-form4_155778305186808.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,436

F1 · price: Grant of Restricted Stock.

SEC source: 0001628280-19-003520 · wf-form4_155377972523307.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,971

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. These restricted stock units were issued pursuant to the Harte-Hanks, Inc. 2013 Omnibus Incentive Plan and the corresponding Restricted Stock Unit Award Agreement and vest following a period of one full year from the date of grant.

F2 · balance_after: These securities consist of (i) the 23,136 RSUs reported on this form and (ii) 29,971.

SEC source: 0001628280-18-009742 · wf-form4_153297414948465.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,835

F1 · price: These restricted stock units were issued pursuant to the Harte-Hanks, Inc. 2013 Omnibus Incentive Plan, and vest in three equal annual installments. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

SEC source: 0001171843-18-001112 · f4_oconnell021318.xml · derivative · entry 6

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2027-06-01

F2 · derivative.exercise_date: This option was cancelled and converted into the right to receive in cash the amount per share by which $18.00 exceeds the exercise price of the option, subject to any applicable tax witholdings (such amount, the "Option Spread"), upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to the Merger Agreement. The Option Spread for the unvested portion of the option, if any, will be paid in accordance with the schedule described in the Merger Agreement.

SEC source: 0001171843-18-001112 · f4_oconnell021318.xml · derivative · entry 5

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2025-05-29

F2 · derivative.exercise_date: This option was cancelled and converted into the right to receive in cash the amount per share by which $18.00 exceeds the exercise price of the option, subject to any applicable tax witholdings (such amount, the "Option Spread"), upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to the Merger Agreement. The Option Spread for the unvested portion of the option, if any, will be paid in accordance with the schedule described in the Merger Agreement.

SEC source: 0001171843-18-001112 · f4_oconnell021318.xml · derivative · entry 4

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2024-05-09

F2 · derivative.exercise_date: This option was cancelled and converted into the right to receive in cash the amount per share by which $18.00 exceeds the exercise price of the option, subject to any applicable tax witholdings (such amount, the "Option Spread"), upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to the Merger Agreement. The Option Spread for the unvested portion of the option, if any, will be paid in accordance with the schedule described in the Merger Agreement.

SEC source: 0001171843-18-001112 · f4_oconnell021318.xml · derivative · entry 3

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2023-05-22

F2 · derivative.exercise_date: This option was cancelled and converted into the right to receive in cash the amount per share by which $18.00 exceeds the exercise price of the option, subject to any applicable tax witholdings (such amount, the "Option Spread"), upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to the Merger Agreement. The Option Spread for the unvested portion of the option, if any, will be paid in accordance with the schedule described in the Merger Agreement.

SEC source: 0001171843-18-001112 · f4_oconnell021318.xml · derivative · entry 2

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2023-03-01

F2 · derivative.exercise_date: This option was cancelled and converted into the right to receive in cash the amount per share by which $18.00 exceeds the exercise price of the option, subject to any applicable tax witholdings (such amount, the "Option Spread"), upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to the Merger Agreement. The Option Spread for the unvested portion of the option, if any, will be paid in accordance with the schedule described in the Merger Agreement.

SEC source: 0001171843-18-001112 · f4_oconnell021318.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: This common stock was purchased for $18.00 per share share in cash, subject to any required withholding of taxes and without interest, upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to that certain Agreement and Plan of Merger by and among Mallinckrodt plc, Sun Acquisition Co. and Sucampo Pharmaceuticals, Inc. dated December 23, 2017 (the "Merger Agreement"). The common stock consisted of restricted stock units that were accelerated as a result of the Merger Agreement.

SEC source: 0001179110-17-012708 · edgar.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,121

F1 · shares: Represents shares withheld to cover taxes owed upon the vesting of 1,550 restricted stock units.

SEC source: 0001179110-17-012612 · edgar.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,921

F1 · shares: Represents shares withheld to cover taxes owed upon the vesting of 1,205 restricted stock units.

SEC source: 0001179110-17-012567 · edgar.xml · nonDerivative · entry 2

OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,543

F1 · shares: Represents shares withheld to cover taxes owed upon the vesting of 1,340 restricted stock units.

SEC source: 0001179110-17-012567 · edgar.xml · derivative · entry 3

OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,936

Underlying: Common Stock · 46,936 shares

Expires 2027-09-19

F2 · derivative.exercise_date: The grant becomes exercisable in four equal annual installments beginning with the first anniversary of the date of grant.

SEC source: 0001179110-17-012567 · edgar.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,235

SEC source: 0001179110-17-012521 · edgar.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,795

F1 · shares: Represents shares withheld to cover taxes owed upon the vesting of 1,740 restricted stock units.

F1 · price: Represents shares withheld to cover taxes owed upon the vesting of 1,740 restricted stock units.

SEC source: 0001179110-17-012066 · edgar.xml · derivative · entry 4

OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,028 shares

Expires 2017-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") acquired by the reporting person on 9/2/14 under the MSPP in lieu of cash bonus; converted into shares of Common Stock on a one-for-one basis on 9/5/17, the first business day following expiration of the deferral period selected by the reporting person. RSU price is equal to 75% of the lowest closing price for the underlying Common Stock in the fiscal quarter ended August 31, 2014.

SEC source: 0001179110-17-012066 · edgar.xml · nonDerivative · entry 2

OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,693

F1 · shares: Restricted stock units ("RSUs") acquired by the reporting person on 9/2/14 under the MSPP in lieu of cash bonus; converted into shares of Common Stock on a one-for-one basis on 9/5/17, the first business day following expiration of the deferral period selected by the reporting person. RSU price is equal to 75% of the lowest closing price for the underlying Common Stock in the fiscal quarter ended August 31, 2014.

SEC source: 0001179110-17-012066 · edgar.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,168

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units ("RSUs") acquired by the reporting person on 9/2/14 under the MSPP in lieu of cash bonus; converted into shares of Common Stock on a one-for-one basis on 9/5/17, the first business day following expiration of the deferral period selected by the reporting person. RSU price is equal to 75% of the lowest closing price for the underlying Common Stock in the fiscal quarter ended August 31, 2014.

SEC source: 0001179110-17-012066 · edgar.xml · derivative · entry 3

OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,954

Underlying: Common Stock · 4,954 shares

Expires 2020-09-01

F2 · derivative.exercise_price: Acquired under the Scholastic Corporation Management Stock Purchase Plan in lieu of cash bonus; to be converted into shares of Common Stock on a one-for-one basis upon expiration of the deferral period selected by the reporting person. Vests on third anniversary of the award date. Price is equal to 75% of the lowest closing price for the underlying Common Stock in the fiscal quarter ended August 31, 2017.

SEC source: 0001179110-17-011201 · edgar.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,140

F1 · shares: Represents shares withheld to cover taxes owed upon the vesting of 4,665 restricted stock units.

SEC source: 0001171843-17-003480 · f4_oconnell060517.xml · derivative · entry 2

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 10,000 shares

Expires 2027-06-01

F2 · derivative.exercise_date: Vesting commences July 1, 2017 in 12-monthly installments.

SEC source: 0001171843-17-003480 · f4_oconnell060517.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,930

F1 · security: Common stock granted consists of restricted stock units that vest in a single installment on June 1, 2018.

SEC source: 0001179110-17-000640 · edgar.xml · nonDerivative · entry 1

OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,865

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.30 to $47.52, inclusive. The reporting person undertakes to provide to Scholastic Corporation, any holder of Scholastic Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.